BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 31, 2014
View Archived Issues
Development of novel potent oxytocin receptor agonists to correct aberrant preterm lactation
Read More
Burnet Institute and Artes Biotechnology to develop new type of malaria vaccine
Read More
Pfizer reflects on achievements of second quarter 2014
Read More
AstraZeneca to acquire Almirall's respiratory business
Read More
AstraZeneca and Kyowa Hakko Kirin form clinical immuno-oncology collaboration
Read More
Roche and AmorChem collaborate in myotonic muscular dystrophy 1
Read More
Zealand Pharma and Boehringer Ingelheim collaborate in cardiometabolic disease
Read More
Immune Pharmaceuticals initiates phase II trial of bertilimumab in bullous pemphigoid
Read More
Novel Nrf2 pathway activator tested in animal model for treatment of ischemia-reperfusion injury
Read More
Piramal Enterprises designs novel agents for cancer
Read More
New compounds for bacterial infections disclosed by Actelion Pharmaceuticals
Read More
Promising preclinical results with anti-CD154 antibody BMS-986004 in kidney transplant models
Read More
Merck KGaA patents new piperidinylcarbazole derivatives for malaria
Read More
Gilead Sciences synthesizes novel antiretrovirals
Read More
Aurigene Discovery Technologies divulges novel BTK inhibitors
Read More
Phase II efficacy, safety and favorable pharmacometrics of TOL-101
Read More
Stivarga approved in the E.U. for gastrointestinal stromal tumors
Read More
Regeneron and Sanofi report topline data from nine phase III trials of alirocumab
Read More
Baxter divests commercial vaccines business to Pfizer
Read More
Incyte and Genzyme to evaluate combination of two novel cancer immunotherapies
Read More
New start-up Emulate to commercialize Wyss Institute's Organs-on-Chips technology
Read More
Amgen reveals milestones of second quarter 2014
Read More
Glide Pharmaceutical licenses rights from FScan to prostate cancer diagnostic technology
Read More
Angelini to commercialize dalbavancin in select European countries
Read More
Evotec identifies novel targets in Alzheimer's disease collaboration with Janssen
Read More